Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism-Reference-Cited by-同舟云学术

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism

Published:2017-04 Issue:4 Volume:69 Page:545-550
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Seccia Teresa M.¹,Caroccia Brasilina¹,Adler Gail K.¹,Maiolino Giuseppe¹,Cesari Maurizio¹,Rossi Gian Paolo¹

Affiliation:

1. From the Clinica dell’Ipertensione Arteriosa, Department of Medicine—DIMED, University of Padua, Italy (T.M.S., B.C., G.M., M.C., G.P.R.); and Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (G.K.A.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.116.08956

Reference69 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

2. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

3. Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

4. Rates and Implications for Hospitalization of Patients ≥65 Years of Age With Atrial Fibrillation/Flutter

5. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Management of Primary Aldosteronism: An Update;Hypertension;2024-09

2. Aldosterone Effect on Cardiac Structure and Function;Current Cardiology Reviews;2024-07

3. Primary aldosteronism: An underdiagnosed clinical entity;Journal of Current Cardiology;2024-05

4. Vasorelaxant Effect of 6β-Hydroxybetulinic Acid;Revista Brasileira de Farmacognosia;2024-02-08

5. Expression of functional mineralocorticoid receptor (MR) and G-protein coupled estrogen receptor (GPER) in human T lymphocytes;Steroids;2023-12